Venner Shipley LLP

United Kingdom

Back to Profile

1-16 of 16 for Venner Shipley LLP Sort by
Query
Aggregations
IP Type
        Patent 11
        Trademark 5
Jurisdiction
        World 11
        Europe 5
Date
2024 6
2023 5
2022 1
Before 2020 4
IPC Class
C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings 10
A61P 35/00 - Antineoplastic agents 8
A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole 6
C09B 47/00 - PorphinesAzaporphines 4
A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation 3
See more
NICE Class
42 - Scientific, technological and industrial services, research and design 5
16 - Paper, cardboard and goods made from these materials 4
35 - Advertising and business services 4
09 - Scientific and electric apparatus and instruments 3
41 - Education, entertainment, sporting and cultural services 3
See more

1.

PYROPHEOPHORBIDE ANALOGUES FOR THERAPY AND DIAGNOSIS

      
Application Number GB2024051421
Publication Number 2024/246549
Status In Force
Filing Date 2024-05-31
Publication Date 2024-12-05
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Marcuccio, Sebastian M.
  • Cho, Honsue
  • Donner, Christopher D.
  • Novakovic, Sacha
  • Ailuri, Ramesh

Abstract

The present invention relates to pyropheophorbide a analogues and their pharmaceutically acceptable salts, and compositions comprising pyropheophorbide a analogues and their pharmaceutically acceptable salts. Pyropheophorbide a analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of pyropheophorbide a analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C09B 47/00 - PorphinesAzaporphines
  • A61K 31/40 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • A61K 49/00 - Preparations for testing in vivo
  • A61K 51/04 - Organic compounds
  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings

2.

PURPURIN ANALOGS FOR USE IN PHOTODYNAMIC THERAPY

      
Application Number GB2024051422
Publication Number 2024/246550
Status In Force
Filing Date 2024-05-31
Publication Date 2024-12-05
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Marcuccio, Sebastian M.
  • Cho, Honsue
  • Donner, Christopher D.
  • Novakovic, Sacha

Abstract

The present invention relates to purpurin analogues and their pharmaceutically acceptable salts, and compositions comprising purpurin analogues and their pharmaceutically acceptable salts. Purpurin analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of purpurin analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C09B 47/00 - PorphinesAzaporphines
  • A61K 31/40 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • A61K 49/00 - Preparations for testing in vivo
  • A61K 51/04 - Organic compounds
  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings

3.

PORPHYRIN AND PHOSPHONIUM-PORPHYRIN BASED COMPOUNDS FOR PHOTODYNAMIC THERAPY AND DIAGNOSTICS

      
Application Number EP2023083438
Publication Number 2024/115524
Status In Force
Filing Date 2023-11-28
Publication Date 2024-06-06
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Marcuccio, Sebastian M.
  • Cho, Honsue
  • Donner, Christopher D.
  • Novakovic, Sacha
  • Ailuri, Ramesh

Abstract

The present invention relates to chlorin e6 analogues and their pharmaceutically acceptable salts, and compositions comprising chlorin e6 analogues and their pharmaceutically acceptable salts. Chlorin e6 analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of chlorin e6 analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C07F 9/6561 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • A61N 5/06 - Radiation therapy using light
  • A61P 35/00 - Antineoplastic agents
  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings

4.

NOVEL CHLORIN E6 ANALOGUES

      
Application Number EP2023083439
Publication Number 2024/115525
Status In Force
Filing Date 2023-11-28
Publication Date 2024-06-06
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Marcuccio, Sebastian M.
  • Cho, Honsue
  • Donner, Christopher D.
  • Stephens, Andrew N.

Abstract

The present invention relates to chlorin e6 analogues and their pharmaceutically acceptable salts, and compositions comprising chlorin e6 analogues and their pharmaceutically acceptable salts. Chlorin e6 analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of chlorin e6 analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C07H 15/26 - Acyclic or carbocyclic radicals, substituted by hetero rings
  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings
  • C07F 9/54 - Quaternary phosphonium compounds
  • A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
  • A61P 27/02 - Ophthalmic agents
  • A61P 31/04 - Antibacterial agents
  • A61P 31/10 - Antimycotics
  • A61P 31/12 - Antivirals
  • A61P 35/00 - Antineoplastic agents
  • A61P 43/00 - Drugs for specific purposes, not provided for in groups

5.

PHYLLOCHLORIN ANALOGUES SUITABLE FOR USE IN PHOTODYNAMIC THERAPY (PDT)

      
Application Number EP2023064604
Publication Number 2024/114953
Status In Force
Filing Date 2023-05-31
Publication Date 2024-06-06
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Marcuccio, Sebastian M.
  • Stephens, Andrew N.
  • Donner, Christopher D.
  • Cho, Honsue

Abstract

The present invention relates to phyllochlorin analogues and their pharmaceutically acceptable salts, and compositions comprising phyllochlorin analogues and their pharmaceutically acceptable salts. Phyllochlorin analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of phyllochlorin analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings
  • A61P 35/00 - Antineoplastic agents
  • A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
  • C07F 9/6561 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
  • A61K 41/10 - Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
  • C09B 47/00 - PorphinesAzaporphines
  • C09K 11/06 - Luminescent, e.g. electroluminescent, chemiluminescent, materials containing organic luminescent materials
  • G01N 33/58 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving labelled substances

6.

CHLORIN K ANALOGUES SUITABLE FOR USE IN PHOTODYNAMIC THERAPY (PDT)

      
Application Number EP2023064608
Publication Number 2024/114954
Status In Force
Filing Date 2023-05-31
Publication Date 2024-06-06
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Marcuccio, Sebastian M.
  • Stephens, Andrew N.
  • Donner, Christopher D.
  • Cho, Honsue

Abstract

The present invention relates to chlorin k analogues and their pharmaceutically acceptable salts, and compositions comprising chlorin k analogues and their pharmaceutically acceptable salts. Chlorin k analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of chlorin k analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C07D 491/22 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or in which the condensed system contains four or more hetero rings
  • A61K 31/409 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
  • A61P 35/00 - Antineoplastic agents
  • A61K 41/10 - Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
  • C09B 47/00 - PorphinesAzaporphines
  • C09K 11/06 - Luminescent, e.g. electroluminescent, chemiluminescent, materials containing organic luminescent materials
  • G01N 33/58 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving labelled substances

7.

Miscellaneous Design

      
Application Number 018937374
Status Registered
Filing Date 2023-10-13
Registration Date 2024-05-01
Owner Venner Shipley LLP (United Kingdom)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 16 - Paper, cardboard and goods made from these materials
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 45 - Legal and security services; personal services for individuals.

Goods & Services

Computer software and computer programmes for managing data and for data processing; computer software and computer programmes for use in the field of intellectual property; computer software and publications in electronic form supplied online from databases and/or facilities provided on the Internet (including websites); downloadable computer application software in the fields of intellectual property and brand creation; computer software to enable searching of data; application development tool programs for personal handheld computers; data recordings including audio, video, still and moving images and text; downloadable electronic publications. Printed matter; printed publications, leaflets, pamphlets, brochures, reports, manuals and books; information circulars; diaries; calendars; note pads, notecards; greetings cards; stationery and writing instruments; photographs; drawings; instructional publications; instructional and teaching materials. Business research services; business consultation services; business searching, enquiries and investigations; provision of information and advisory services all relating to the aforesaid services; business information and advisory services; business appraisals and evaluations in business matters; compilation and provision of company information; preparation of business and/or market reports; database management; business franchising advisory services; brand creation services; rebranding services; market research services; marketing advice and consultancy services; provision of information, consultancy and advisory services relating to all the aforesaid services. Financial appraisals and evaluations of intellectual property assets and portfolios; intellectual property valuation services; business appraisals for financial valuation in the field of intellectual property. Education and training services in the field of intellectual property; seminars, workshops, conferences, symposia and exhibitions; library services; publishing services; providing online electronic publications; translation services; provision of information, consultancy and advisory services relating to all the aforesaid services. Technical searching and research services; technical drawings; preparation of technical drawings; new product development services; design of brand names, brand design services; design of trade marks; graphic design services; website design and creation; website design consultancy; website development; website management and maintenance; website hosting services; computer programming services; provision of information; trade mark creation services; consultancy and advisory services relating to all the aforesaid services. Legal services; intellectual property agency and attorney services; professional, advisory, licensing and consultation services relating to intellectual property; professional advisory and consultancy services relating to industrial and intellectual property; establishment, filing, prosecution, protection, management, maintenance, renewal, exploitation, acquisition, licensing and enforcement of intellectual property rights; searching and research services relating to intellectual property; legal research services; intellectual property agency services; patent agency services; trade mark agency services; intellectual property auditing services; provision of expert appraisals relating to intellectual property; legal information services; legal mediation services; legal support services; legal investigation and research services; legal consultancy services; legal watching services; legal advocacy services; legal services relating to copyright licensing, management, exploitation and enforcement; legal due diligence services; computer software licensing services; legal document preparation services; trade mark monitoring [legal services]; record keeping services in relation to intellectual property; provision of information; brand management services; name creation services; consultancy and advisory services relating to all the aforesaid services.

8.

Venner Shipley

      
Application Number 018937362
Status Registered
Filing Date 2023-10-13
Registration Date 2024-04-25
Owner Venner Shipley LLP (United Kingdom)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 16 - Paper, cardboard and goods made from these materials
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 45 - Legal and security services; personal services for individuals.

Goods & Services

Computer software and computer programmes for managing data and for data processing; computer software and computer programmes for use in the field of intellectual property; computer software and publications in electronic form supplied online from databases and/or facilities provided on the Internet (including websites); downloadable computer application software in the fields of intellectual property and brand creation; computer software to enable searching of data; application development tool programs for personal handheld computers; data recordings including audio, video, still and moving images and text; downloadable electronic publications. Printed matter; printed publications, leaflets, pamphlets, brochures, reports, manuals and books; information circulars; diaries; calendars; note pads, notecards; greetings cards; stationery and writing instruments; photographs; drawings; instructional publications; instructional and teaching materials. Business research services; business consultation services; business searching, enquiries and investigations; provision of information and advisory services all relating to the aforesaid services; business information and advisory services; business appraisals and evaluations in business matters; compilation and provision of company information; preparation of business and/or market reports; database management; business franchising advisory services; brand creation services; rebranding services; market research services; marketing advice and consultancy services; provision of information, consultancy and advisory services relating to all the aforesaid services. Financial appraisals and evaluations of intellectual property assets and portfolios; intellectual property valuation services; business appraisals for financial valuation in the field of intellectual property. Education and training services in the field of intellectual property; seminars, workshops, conferences, symposia and exhibitions; library services; publishing services; providing online electronic publications; translation services; provision of information, consultancy and advisory services relating to all the aforesaid services. Technical searching and research services; technical drawing; preparation of technical drawings; new product development services; design of brand names, brand design services; design of trade marks; graphic design services; website design and creation; website design consultancy; website development; website management and maintenance; website hosting services; computer programming services; trademark creation services; provision of information, consultancy and advisory services relating to all the aforesaid services. Legal services; intellectual property agency and attorney services; professional, advisory, licensing and consultation services relating to intellectual property; professional advisory and consultancy services relating to industrial and intellectual property; establishment, filing, prosecution, protection, management, maintenance, renewal, exploitation, acquisition, licensing and enforcement of intellectual property rights; searching and research services relating to intellectual property; legal research services; intellectual property agency services; patent agency services; trade mark agency services; intellectual property auditing services; provision of expert appraisals relating to intellectual property; legal information services; legal mediation services; legal support services; legal investigation and research services; legal consultancy services; legal watching services; legal advocacy services; legal services relating to copyright licensing, management, exploitation and enforcement; legal due diligence services; computer software licensing services; legal document preparation services; trade mark monitoring [legal services]; record keeping services in relation to intellectual property; brand management services; name creation services; provision of information, consultancy and advisory services relating to all the aforesaid services.

9.

PHOTODYNAMIC THERAPY AND DIAGNOSIS

      
Application Number EP2022083551
Publication Number 2023/094677
Status In Force
Filing Date 2022-11-28
Publication Date 2023-06-01
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Marcuccio, Sebastian M.
  • Stephens, Andrew N.
  • Donner, Christopher D.
  • Cho, Honsue
  • Novakovic, Sacha
  • Ailuri, Ramesh

Abstract

The present invention relates to phyllochlorin analogues and their pharmaceutically acceptable salts, and compositions comprising phyllochlorin analogues and their pharmaceutically acceptable salts. Phyllochlorin analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of phyllochlorin analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings
  • A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
  • A61P 35/00 - Antineoplastic agents

10.

PHOTODYNAMIC THERAPY AND DIAGNOSIS

      
Application Number EP2022083553
Publication Number 2023/094679
Status In Force
Filing Date 2022-11-28
Publication Date 2023-06-01
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Marcuccio, Sebastian M.
  • Stephens, Andrew N.
  • Donner, Christopher D.
  • Cho, Honsue
  • Novakovic, Sacha
  • Ailuri, Ramesh

Abstract

The present invention relates to chlorin e4 analogues and their pharmaceutically acceptable salts, and compositions comprising chlorin e4 analogues and their pharmaceutically acceptable salts. Chlorin e4 analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of chlorin e4 analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings
  • A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
  • A61P 35/00 - Antineoplastic agents

11.

PHOTODYNAMIC THERAPY AND DIAGNOSIS

      
Application Number EP2022083554
Publication Number 2023/094680
Status In Force
Filing Date 2022-11-28
Publication Date 2023-06-01
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Marcuccio, Sebastian M.
  • Stephens, Andrew N.
  • Donner, Christopher D.
  • Cho, Honsue
  • Novakovic, Sacha

Abstract

The present invention relates to reduced chlorin analogues and their pharmaceutically acceptable salts, and compositions comprising reduced chlorin analogues and their pharmaceutically acceptable salts. Reduced chlorin analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of reduced chlorin analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings
  • A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

12.

PHOTODYNAMIC THERAPY AND DIAGNOSIS

      
Application Number EP2021083253
Publication Number 2022/112537
Status In Force
Filing Date 2021-11-26
Publication Date 2022-06-02
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor
  • Cho, Honsue
  • Stephens, Andrew N.
  • Marcuccio, Sebastian M.
  • Donner, Christopher D.
  • Stockton, Kieran P.
  • Skene, Colin
  • Faber, Jonathan

Abstract

The present invention relates to phyllochlorin analogues and their pharmaceutically acceptable salts, and compositions comprising phyllochlorin analogues and their pharmaceutically acceptable salts. Phyllochlorin analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment. The present invention also relates to the use of phyllochlorin analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.

IPC Classes  ?

  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings
  • A61P 35/00 - Antineoplastic agents
  • A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

13.

BROOKES IP

      
Application Number 013892575
Status Registered
Filing Date 2015-03-30
Registration Date 2015-09-07
Owner Venner Shipley LLP (United Kingdom)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 16 - Paper, cardboard and goods made from these materials
  • 35 - Advertising and business services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 45 - Legal and security services; personal services for individuals.

Goods & Services

Computer software and computer programmes for managing data and for data processing; computer software and computer programmes for use in the field of intellectual property; computer software and publications in electronic form supplied online from databases and/or facilities provided on the Internet (including websites); computer software to enable searching of data; application development tool programmes for personal handheld computers; data recordings including audio, video, still and moving images and text; downloadable electronic publications; none of the aforesaid goods relating to veterinary care or animal welfare. Printed publications in the field of intellectual property; printed reports; newsletters; brochures, guides, manuals, pamphlets and leaflets; information circulars; diaries; calendars; stationery and writing instruments; photographs; drawings; instructional and teaching materials; none of the aforesaid goods relating to veterinary care or animal welfare. Brand management services; name creation services; market research services; business information and advisory services; business research services; business enquiries and investigations; compilation and provision of company information; preparation of business and/or market reports; database management; business franchising advisory services; marketing advice and consultancy services. Education and training services in the field of intellectual property; seminars, workshops, conferences, symposia and exhibitions; library services; publishing services; providing online electronic publications; translation services; translation services; none of the aforesaid services relating to veterinary care or animal welfare. Technical searching and research services; drawing services; preparation of technical drawings; new product development services. Professional advisory and consultancy services, all relating to industrial and intellectual property; intellectual property portfolio management and auditing; legal services; legal searching and research services; management, establishment, enforcement, maintenance and exploitation of patents, industrial designs, trade marks, copyright and other intellectual property rights; intellectual property agency and attorney services; due diligence services; computer software licensing services; record keeping services in relation to intellectual property.

14.

CHLORIN DERIVATIVE USEFUL IN PHOTODYNAMIC THERAPY AND DIAGNOSIS

      
Application Number GB2013053285
Publication Number 2014/091241
Status In Force
Filing Date 2013-12-13
Publication Date 2014-06-19
Owner
  • RMW CHO GROUP LIMITED (China)
  • VENNER SHIPLEY LLP (United Kingdom)
Inventor Cho, Honsue

Abstract

The present invention relates to chlorin e4 sodium and a process for its preparation. Chlorin e4 sodium is suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example for treating or detecting a tumour. The present invention also relates to a pharmaceutical composition comprising chlorin e4 sodium, to the use of chlorin e4 sodium in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example for treating or detecting a tumour.

IPC Classes  ?

  • C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings
  • A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
  • A61P 3/00 - Drugs for disorders of the metabolism
  • A61P 9/00 - Drugs for disorders of the cardiovascular system
  • A61P 17/00 - Drugs for dermatological disorders
  • A61P 19/00 - Drugs for skeletal disorders
  • A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P 35/00 - Antineoplastic agents
  • A61P 43/00 - Drugs for specific purposes, not provided for in groups

15.

B Brookes Batchellor

      
Application Number 005171021
Status Registered
Filing Date 2006-06-29
Registration Date 2007-10-05
Owner Venner Shipley LLP (United Kingdom)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Intellectual property services; legal services; intellectual property advisory, licensing and consultancy services; technical and legal searching and research services; management, establishment, enforcement, maintenance and exploitation of patents, industrial designs, trade marks, copyright and other intellectual property rights; intellectual property agency and attorney services; translation of programs services; drawing services; preparation of technical drawings; new product development services.

16.

VENNER SHIPLEY

      
Application Number 000788612
Status Registered
Filing Date 1998-04-02
Registration Date 1999-10-04
Owner Venner Shipley LLP (United Kingdom)
NICE Classes  ?
  • 16 - Paper, cardboard and goods made from these materials
  • 35 - Advertising and business services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Printed matter; printed publications; leaflets, pamphlets, brochures; reports; manuals and books; instructional publications; instructional and teaching materials. Business research services; business consultation services; business searching, inquiries and investigations; provision of information and advisory services all relating to the aforesaid services. Legal services; intellectual property services; professional, advisory, licensing and consultation services relating to intellectual property; establishment, filing, prosecution, protection, management, maintenance, exploitation, licensing and enforcement of intellectual property rights; searching and research services relating to intellectual property; legal research services; Intellectual property agency services; patent agency services; trade mark agency services; name and trade mark creation services; translation services; computer programming services; provision of information and advisory services relating to all the aforesaid services.